Tesla
TSLA
Amazon
AMZN
Meta Platforms
META
4
Oracle
ORCL
5
Salesforce
CRM
US Stock MarketDetailed Quotes
SLXN Silexion Therapeutics
- 1.030
- +0.327+46.51%
Close Apr 23 16:00 ET
- 0.962
- -0.068-6.64%
Pre 05:26 ET
8.95MMarket Cap-0.12P/E (TTM)
1.290High0.759Low67.15MVolume0.759Open0.703Pre Close74.09MTurnover1283.52%Turnover RatioLossP/E (Static)8.69MShares122.01852wk High-2.24P/B5.39MFloat Cap0.57552wk Low--Dividend TTM5.23MShs Float122.013Historical High--Div YieldTTM75.55%Amplitude0.575Historical Low1.103Avg Price1Lot Size
Silexion Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -85.38%-8.4M | -132.78%-2.93M | -287.30%-2.65M | 36.46%-1.07M | -92.32%-1.75M | -35.80%-4.53M | -1.26M | -685K | -1.68M | -911K |
| Net income from continuing operations | -223.39%-16.52M | -3.99%-1.75M | -1,366.01%-11.86M | 20.63%-1.49M | -91.52%-1.42M | -46.44%-5.11M | ---1.68M | ---809K | ---1.88M | ---743K |
| Operating gains losses | 1,700.00%16K | ---- | ---- | ---- | ---- | ---1K | --0 | ---1K | ---- | ---- |
| Depreciation and amortization | -44.44%25K | -300.00%-12K | 120.00%22K | -50.00%7K | -46.67%8K | -21.05%45K | --6K | --10K | --14K | --15K |
| Other non cash items | 1,094.97%3.8M | -402.13%-236K | 3,434.26%3.82M | -70.14%83K | 747.62%136K | 218.66%318K | ---47K | --108K | --278K | ---21K |
| Change In working capital | -1,916.09%-1.58M | -320.23%-947K | -1,620.00%-430K | 343.55%302K | -160.31%-505K | -63.60%87K | --430K | ---25K | ---124K | ---194K |
| -Change in receivables | ---- | ---- | -170.83%-17K | 110.00%2K | -500.00%-44K | ---- | ---- | --24K | ---20K | --11K |
| -Change in prepaid assets | -91.79%-631K | 82.95%-22K | -110.61%-417K | -1,360.00%-63K | -1,742.86%-129K | -179.28%-329K | ---129K | ---198K | --5K | ---7K |
| -Change in payables and accrued expense | -394.29%-1.29M | -271.98%-884K | -336.59%-388K | 518.39%364K | -149.02%-381K | 993.88%438K | --514K | --164K | ---87K | ---153K |
| -Change in other current assets | -311.11%-38K | ---- | ---- | ---- | ---- | --18K | ---- | ---- | ---- | ---- |
| -Change in other working capital | 1,045.00%378K | -247.62%-62K | 2,713.33%392K | 95.45%-1K | 208.89%49K | 54.02%-40K | --42K | ---15K | ---22K | ---45K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -85.38%-8.4M | -132.78%-2.93M | -287.30%-2.65M | 36.46%-1.07M | -92.32%-1.75M | -35.80%-4.53M | ---1.26M | ---685K | ---1.68M | ---911K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -103.84%-22K | 0 | -122.22%-16K | 0 | -101.18%-6K | 209.35%573K | -4K | 72K | -2K | 507K |
| Net PPE purchase and sale | -133.33%-22K | --0 | -122.22%-16K | --0 | ---6K | 265.00%66K | ---4K | --72K | ---2K | --0 |
| Net investment purchase and sale | --0 | --0 | --0 | --0 | --0 | 204.75%507K | --0 | --0 | --0 | --507K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -103.84%-22K | --0 | -122.22%-16K | --0 | -101.18%-6K | 209.35%573K | ---4K | --72K | ---2K | --507K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 877.78%5.1M | 2.18M | 2.92M | 0 | -81.03%522K | 0 | 0 | 522K | 0 | |
| Net issuance payments of debt | ---250K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net common stock issuance | --3.05M | --2.43M | --620K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net preferred stock issuance | --0 | --0 | --0 | --0 | ---- | -81.01%522K | --0 | --0 | --522K | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | --0 | ---- | ---- | --0 | --0 |
| Net other financing activities | --2.3M | --0 | --2.3M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 877.78%5.1M | --2.18M | --2.92M | --0 | --0 | -81.03%522K | --0 | --0 | --522K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -44.10%4.65M | -65.19%2.02M | -73.09%1.75M | -64.27%2.83M | -44.10%4.65M | -17.59%8.31M | --5.81M | --6.49M | --7.92M | --8.31M |
| Current changes in cash | 3.49%-3.31M | 41.16%-742K | 140.95%251K | 7.87%-1.07M | -335.15%-1.76M | -210.21%-3.43M | ---1.26M | ---613K | ---1.16M | ---404K |
| Effect of exchange rate changes | 73.48%-61K | -111.70%-11K | 137.88%25K | 93.14%-19K | -394.74%-56K | 65.52%-230K | --94K | ---66K | ---277K | --19K |
| End cash Position | -72.66%1.27M | -72.66%1.27M | -65.19%2.02M | -73.09%1.75M | -64.27%2.83M | -44.10%4.65M | --4.65M | --5.81M | --6.49M | --7.92M |
| Free cash flow | -85.38%-8.42M | -132.04%-2.93M | -286.25%-2.67M | 36.53%-1.07M | -92.97%-1.76M | -34.55%-4.54M | ---1.26M | ---691K | ---1.68M | ---911K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀